Sensient Technologies
Sensient Technologies' revenue rose 3.5% to $1.6 billion in fiscal 2025. Its operating margin was 12.8%, up from 12.3% a year earlier. Free cash flow was $38 million, down 60.8%. It paid out $70 million in dividends and buybacks, 181% of free cash flow. The diluted share count rose 0.5%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Revenue and margins
Net income and earnings per share
From fiscal 2016 to 2025, earnings per share grew 1.3% a year and net income 0.7% a year, as buybacks cut the share count by 5%.
Returns on capital
Cash flow
Payouts and share count
Valuation
Two ways to value Sensient Technologies yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.
Discounted cash flow (DCF)
A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from Sensient Technologies' 10-K (or, for net cash and shares, its latest 10-Q) and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.
Value per share on three example scenarios, from Sensient Technologies' fiscal 2025 free cash flow of $38M, net cash of −$673M at December 31, 2025 and 43 million diluted shares, from its filings. The scenarios are fitted to Sensient Technologies: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, 3.9% a year; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 12%: 11% for a cyclical or higher-risk business (Specialty Chemicals), plus 1 point as a smaller company, worth $5.6B; the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target. A negative value means Sensient Technologies' net debt is larger than what that scenario's cash flows are worth today.
- Last close, October 26, 2026
- $131.45
- Value on these assumptions, against the last close
- —
- Cash flows in years 1 to 10, valued today
- —
- Everything after year 10, valued today
- —
- Plus net cash
- —
- Share of value from after year 10
How the value changes with two assumptions
Price-to-earnings (P/E) method
Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.
Value per share on three example scenarios, from Sensient Technologies' earnings per share of $3.71 (over the last four quarters). Each grows earnings for a year at the cash flow scenarios' rates and applies a multiple to next year's earnings: 27.6×, the middle of Sensient Technologies' own P/E today, its peers' median and its sector's median (its peers' median) for the base scenario, 20% less and more for the cautious and optimistic ones. The price is brought back a year at 13%, 12% and 11%. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $131.45
- Value at this multiple, against the last close
- —
- Sensient Technologies' P/E at the last close
- 35.4×
| Company | Last close | Earnings per share | P/E today |
|---|---|---|---|
| IngevityNGVT | $71.03 | $1.50 | 47.4× |
| Sensient TechnologiesSXT | $131.45 | $3.71 | 35.4× |
| Quaker ChemicalKWR | $154.87 | $5.61 | 27.6× |
| InnospecIOSP | $99.18 | $4.90 | 20.2× |
Balance sheet
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 26 | 21 | 29 | 27 | 36 |
| Debt incl. finance leases | 512 | 631 | 645 | 614 | 709 |
| Net debt (negative means net cash) | 486 | 610 | 616 | 587 | 673 |
| Net debt to EBITDA | 2.2x | 2.5x | 2.9x | 2.3x | 2.5x |
| Debt to equity | 0.6x | 0.6x | 0.6x | 0.6x | 0.6x |
| Interest coverage | 13.6x | 13.5x | 6.2x | 6.7x | 7.0x |
| Current ratio | 3.2x | 3.4x | 4.0x | 3.5x | 4.1x |
| Quick ratio | 1.4x | 1.4x | 1.4x | 1.3x | 1.5x |
Insider trades
Over the 12 months between October 27, 2025 and October 26, 2026, 2 insiders bought $291,167 of Sensient Technologies shares on the open market, and 5 insiders sold $234.1 million.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 5, 2026 | Mario FerruzziDirector | Sold | 1,200 | $129.48 | $155,376 | Form 4 |
| May 18, 2026 | Thierry HoangVP, Asia Pacific Group | Sold | 400 | $115.19 | $46,076 | Form 4 |
| May 4, 2026 | Thierry HoangVP, Asia Pacific Group | Sold | 439 | $114.15 | $50,112 | Form 4 |
| Apr 30, 2026 | Anstalt Winder10% owner | Sold | 2,127,566 | $109.69 | $233.4 million | Form 4 |
| Apr 30, 2026 | Steven B MorrisPresident, Color Group | Sold | 200 | $114.58 | $22,916 | Form 4 |
| Dec 3, 2025 | Essie WhitelawDirector | Sold | 3,985 | $95.02 | $378,655 | Form 4 |
| Nov 20, 2025 | Essie WhitelawDirector | Sold | 533 | $93.22 | $49,723 | Form 4 |
| Nov 4, 2025 | David J. PlautzVP and Treasurer | Bought | 2,150 | $92.98 | $199,907 | Form 4 |
| Nov 3, 2025 | Joseph CarleoneDirector | Bought | 1,000 | $91.26 | $91,260 | Form 4 |
Piotroski F-score
The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Fail | Pass | Pass |
| Cash from operations exceeds net income | Pass | Pass | Fail |
| Debt fell relative to assets | Pass | Pass | Fail |
| Current ratio rose | Pass | Fail | Pass |
| Share count didn't rise | Fail | Fail | Fail |
| Gross margin rose | Fail | Pass | Pass |
| Revenue rose relative to assets | Fail | Pass | Pass |
| F-score | 5 of 9 | 7 of 9 | 6 of 9 |
| Accruals ratio | −3.8% | −1.6% | 0.3% |
Compare
Put Sensient Technologies side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Sensient Technologies | FY25 | 3.5% | 12.8% | 2.4% | 8.9% | 2.5x | 6 | |
| Innospec | FY25 | −3.6% | 7.3% | 5.0% | 11.1% | −1.7x | 6 | Compare |
| Quaker Chemical | FY25 | 2.7% | 2.8% | 4.3% | 1.3% | 6.1x | 5 | Compare |
| Minerals Technologies | FY25 | −2.2% | 2.3% | 4.2% | 1.6% | — | 4 | Compare |
| Ingevity | FY25 | −2.7% | 35.9% | 23.4% | 24.6% | 2.1x | 6 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 1,421 | 1,396 | 1,387 | 1,323 | 1,332 | 1,380 | 1,437 | 1,456 | 1,557 | 1,612 |
| Revenue growth | 0.6% | −1.7% | −0.7% | −4.6% | 0.7% | 3.6% | 4.1% | 1.4% | 6.9% | 3.5% |
| Gross profit | 513 | 510 | — | — | 424 | 455 | 489 | 460 | 507 | 539 |
| Research and development | 41 | 41 | 43 | 40 | 38 | 34 | 42 | 48 | 49 | 53 |
| Operating income | 186 | 168 | 203 | 121 | 153 | 170 | 197 | 155 | 192 | 207 |
| Net income | 126 | 90 | 157 | 82 | 110 | 119 | 141 | 93 | 125 | 134 |
| Diluted EPS (US$) | 2.82 | 2.03 | 3.70 | 1.94 | 2.59 | 2.81 | 3.34 | 2.21 | 2.94 | 3.16 |
| Diluted shares (millions) | 45 | 44 | 42 | 42 | 42 | 42 | 42 | 42 | 42 | 43 |
| Cash flow | ||||||||||
| Cash from operations | 184 | 36 | 84 | 177 | 219 | 145 | 12 | 170 | 157 | 128 |
| Capital expenditure | 81 | 56 | 51 | 39 | 52 | 61 | 79 | 88 | 59 | 89 |
| Free cash flow | 102 | −20 | 33 | 138 | 167 | 84 | −67 | 82 | 98 | 38 |
| Dividends paid | 50 | 54 | 57 | 62 | 66 | 67 | 69 | 69 | 69 | 70 |
| Share buybacks | 50 | 87 | 77 | 0 | 0 | 42 | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 31 | 0 | 0 | 14 | 23 | 2 | 0 | 5 |
| Stock-based compensation | 8 | 6 | 0 | −1 | 6 | 10 | 16 | 9 | 10 | 14 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 26 | 29 | 32 | 21 | 25 | 26 | 21 | 29 | 27 | 36 |
| Debt incl. finance leases | 604 | 624 | 710 | 619 | 536 | 512 | 631 | 645 | 614 | 709 |
| Total assets | 1,668 | 1,724 | 1,825 | 1,740 | 1,741 | 1,746 | 1,982 | 2,014 | 2,024 | 2,244 |
| Total liabilities | 832 | 872 | 965 | 859 | 806 | 807 | 982 | 961 | 963 | 1,051 |
| Shareholders' equity | 836 | 852 | 860 | 882 | 934 | 938 | 1,000 | 1,053 | 1,061 | 1,194 |
| Margins and ratios | ||||||||||
| Gross margin | 36.1% | 36.5% | — | — | 31.8% | 32.9% | 34.0% | 31.6% | 32.6% | 33.5% |
| Operating margin | 13.1% | 12.0% | 14.7% | 9.2% | 11.5% | 12.3% | 13.7% | 10.6% | 12.3% | 12.8% |
| Net margin | 8.9% | 6.4% | 11.3% | 6.2% | 8.2% | 8.6% | 9.8% | 6.4% | 8.0% | 8.3% |
| Free cash flow margin | 7.2% | −1.4% | 2.4% | 10.4% | 12.5% | 6.1% | −4.7% | 5.6% | 6.3% | 2.4% |
| Return on capital | 9.5% | 7.1% | 11.8% | 6.5% | 8.3% | 8.9% | 10.0% | 6.8% | 8.8% | 8.9% |
| Return on equity | 15.0% | 10.6% | 18.4% | 9.4% | 12.1% | 12.7% | 14.5% | 9.1% | 11.8% | 11.9% |
| Return on assets | 7.5% | 5.3% | 8.9% | 4.6% | 6.3% | 6.8% | 7.6% | 4.7% | 6.2% | 6.3% |
| Net debt to EBITDA | 2.5x | 2.8x | 2.6x | 3.4x | 2.5x | 2.2x | 2.5x | 2.9x | 2.3x | 2.5x |